ClinicalTrials.Veeva

Menu

Sarcopenia and Peripheral Artery Disease With Chronic Limb Threatening Ischemia (SAC)

Fudan University logo

Fudan University

Status

Completed

Conditions

Chronic Limb Threatening Ischemia
Peripheral Arterial Disease
Sarcopenia

Treatments

Other: Not applicable- observational study

Study type

Observational

Funder types

Other

Identifiers

NCT07037979
2025ZW02

Details and patient eligibility

About

To evaluate the correlation of Sarcopenia Parameters and Peripheral Artery Disease with chronic limb threatening ischaemia.

Full description

Prior researches indicated a relatively high prevalence of sarcopenia among patients of Peripheral Artery Disease. However, the relationship between sarcopenia and progression of Peripheral Artery Disease with chronic limb threatening ischaemia remained poorly understood. Thus, this cohort study aimed to evaluate the correlation of Sarcopenia Parameters, such as psoas muscle area (PMA) and total abdominal muscle area (TAMA) at the L3 vertebral level, measured by computed tomography (CT), and progression of Peripheral Artery Disease with chronic limb threatening ischaemia.

Enrollment

97 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients of Peripheral Artery Disease, including intermittent claudication and Chronic Limb Threatening Ischemia;
  • Patients with Rutherford grade 2-6 between Jan.1 2023 and Dec.31 2024;
  • Patients at age 18-80;
  • Patients underwent an in-hospital routine enhanced whole abdomen to lower extremities CT scan;
  • Patients able to complete the clinical follow-up for 3 months.

Exclusion criteria

  • Poor CT quality or incomplete images;
  • Incomplete clinical data;
  • In-hospital mortality during Jan.1 2023 and Dec.31 2024.

Trial design

97 participants in 1 patient group

patiets with peripheral artery disease
Treatment:
Other: Not applicable- observational study

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems